Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: rare bleeding disorders, growth hormone related disorders and obesity.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
Novo Nordisk employs about 42,700 people in 80 countries and markets its products in around 170 countries.
Novo Nordisk is tagged in 31 assets.
Page 1 of 2.